Skip to main content

Table 1 Bactericidal activity of hexylresorcinol lozenges

From: Bactericidal activity of hexylresorcinol lozenges against oropharyngeal organisms associated with acute sore throat

Challenge organism

Test control count* (log10 cfu/mL ± SD)

Contact time (min)

1

5

10

30

Averagea log reduction (log10 cfu/mL ± SD)

Staphylococcus aureus

6.7 ± 0.1

3.3 ± 0.2

5.7 ± 0.2

5.7 ± 0.2

5.7 ± 0.2

Streptococcus pyogenes

6.6 ± 0.1

2.9 ± 0.2

4.3 ± 0.4

5.6 ± 0.1

5.6 ± 0.1

Moraxella catarrhalis

7.2 ± 0.1

4.7 ± 0.4

6.2 ± 0.1

6.2 ± 0.1

6.2 ± 0.1

Haemophilus influenzae

6.8 ± 0.4

5.8 ± 0.4

5.8 ± 0.4

5.8 ± 0.4

5.8 ± 0.4

Fusobacterium necrophorum

5.5 ± 0.2

4.5 ± 0.2

4.5 ± 0.2

4.5 ± 0.2

4.5 ± 0.2

  1. Bactericidal activity, defined as a decrease in bacterial count (log10 cfu/mL)
  2. cfu colony-forming units, SD standard deviation
  3. *Average of the three test replicates